| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/1997 | WO1997032870A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 09/12/1997 | WO1997032869A1 Taxoids, preparation thereof and pharmaceutical compositions containing same |
| 09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 09/12/1997 | WO1997032858A1 Quinoxaline derivatives as glutamate receptor antagonists |
| 09/12/1997 | WO1997032857A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 09/12/1997 | WO1997032856A1 4-anilinoquinazoline derivatives |
| 09/12/1997 | WO1997032855A1 2-thioxotetrahydropyrimidin-4-one derivatives |
| 09/12/1997 | WO1997032853A1 Triaryl compounds |
| 09/12/1997 | WO1997032850A1 Mcbi analogs of cc-1065 and the duocarmycins |
| 09/12/1997 | WO1997032849A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 09/12/1997 | WO1997032846A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 09/12/1997 | WO1997032844A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 09/12/1997 | WO1997032839A1 9-cis-retinoic acid esters and amides and uses thereof |
| 09/12/1997 | WO1997032607A2 Activated linkers and methods for making and purifying the same |
| 09/12/1997 | WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | WO1997032596A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | WO1997032594A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | WO1997032591A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 09/12/1997 | WO1997032590A1 Compositions and method for evaluating tissue for the presence of cancer cells |
| 09/12/1997 | WO1997032588A2 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men |
| 09/12/1997 | WO1997032587A1 Methods for treating viral infections |
| 09/12/1997 | WO1997032586A1 Caffeine and clemastine for treating respiratory disorders |
| 09/12/1997 | WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | WO1997032584A1 Slow-release pharmaceutical formulations containing mizolastin |
| 09/12/1997 | WO1997032583A1 Use of csaidtm compounds as inhibitors of angiogenesis |
| 09/12/1997 | WO1997032582A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 09/12/1997 | WO1997032581A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 09/12/1997 | WO1997032580A1 3-substituted-4-oxa-1-azabicyclo[3,2,0]heptan-7-one as cysteine protease inhibitors |
| 09/12/1997 | WO1997032579A1 Neural differentiation inducer |
| 09/12/1997 | WO1997032578A1 Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| 09/12/1997 | WO1997032577A1 Antidiabetic composition containing (2s, 3r, 4s)4-hydroxyisoleucine |
| 09/12/1997 | WO1997032576A1 Use of aryl n-substituted carboxamides to kill tumors |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | WO1997032574A1 Serum cholesterol lowering agent |
| 09/12/1997 | WO1997032573A1 Modified release multiple-units dosage composition |
| 09/12/1997 | WO1997032572A2 Materials and methods for enhancing cellular internalization |
| 09/12/1997 | WO1997032565A1 Anti-caries oral compositions |
| 09/12/1997 | WO1997032562A1 Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss |
| 09/12/1997 | WO1997032541A1 Angiogenic lipid formulations |
| 09/12/1997 | WO1997032480A1 A method of killing or inhibiting microbial cells |
| 09/12/1997 | WO1997032479A1 Antiseptic compositions containing chlorobutanol and chlorhexidine |
| 09/12/1997 | WO1997026880A3 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 09/12/1997 | WO1997026320A3 Product for inhibition of attachment of h. influenzae to human cells |
| 09/12/1997 | WO1997025421A3 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 09/12/1997 | WO1997025321A3 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
| 09/12/1997 | WO1997021826A3 Complementary adenoviral vector systems and cell lines |
| 09/12/1997 | WO1997021416A3 Glycoconjugates of opiated substances |
| 09/12/1997 | WO1997018815A3 The use of adenosine uptake inhibitors for treating retinal or optic nerve head damage |
| 09/12/1997 | WO1997017946A3 Method and device for producing a parenteral medicament |
| 09/12/1997 | WO1997011690A3 Inhibitors of regulatory pathways |
| 09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
| 09/12/1997 | WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins |
| 09/12/1997 | CA2249546A1 Triaryl compounds and their use as antiinflammatory |
| 09/12/1997 | CA2248720A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for the preparation thereof |
| 09/12/1997 | CA2248630A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | CA2248555A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | CA2248350A1 Inhibition of proliferation of cells |
| 09/12/1997 | CA2248316A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation |
| 09/12/1997 | CA2248251A1 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination for the production of a pharmaceutical agent for treating a relative and absolute andrgen deficiency in men |
| 09/12/1997 | CA2248195A1 Taxoids, preparation thereof and pharmaceutical compositions containing same |
| 09/12/1997 | CA2248188A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 09/12/1997 | CA2248187A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 09/12/1997 | CA2248134A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 09/12/1997 | CA2248125A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 09/12/1997 | CA2248109A1 Use of aryl n-substituted carboxamides to kill tumors |
| 09/12/1997 | CA2248078A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 09/12/1997 | CA2248065A1 A method of killing or inhibiting microbial cells |
| 09/12/1997 | CA2247933A1 2-thioxotetrahydropyrimidin-4-one derivatives |
| 09/12/1997 | CA2247500A1 Caffeine and clemastine for treating respiratory disorders |
| 09/12/1997 | CA2247480A1 Oligonucleotide analogues |
| 09/12/1997 | CA2247453A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | CA2247121A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | CA2247091A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | CA2244894A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | CA2244733A1 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | CA2243994A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
| 09/12/1997 | CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | CA2220222A1 Angiogenic lipid formulations |
| 09/12/1997 | CA2199351A1 Benzothiophenes, formulations containing same, and methods |
| 09/11/1997 | DE19616992C1 Treating cytomegalovirus infections, e.g. in immuno-suppressed patients |
| 09/11/1997 | DE19610645A1 Kombination von Dehydroepiandrosteron und Aromatasehemmern und Verwendung dieser Kombination zur Herstellung eines Arzeimittels zur Behandlung eines relativen und absoluten Androgenmangels beim Mann Combination of dehydroepiandrosterone and aromatase inhibitors and the use of this combination being Arzeimittels for treating a relative and absolute androgen deficiency in men |
| 09/11/1997 | DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells |
| 09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
| 09/11/1997 | DE19608653A1 Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation |
| 09/11/1997 | DE19608588A1 Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation |
| 09/11/1997 | DE19608012A1 Stabilisation of super-saturated medicinal solutions by crystallisation inhibitors |
| 09/11/1997 | CA2199415A1 Stable aqueous solubilizates of carotenoids and vitamins |
| 09/11/1997 | CA2199414A1 Stable carotenoid emulsions suitable for parenteral administration |
| 09/10/1997 | EP0794258A2 Saccharide composition comprising maltooligosylturanose and maltooligosylparatinose, its preparation and uses |
| 09/10/1997 | EP0794194A1 A process for the preparation of 2'-deoxy-2'-halocoformycins or stereoisomers thereof |
| 09/10/1997 | EP0794184A1 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same |
| 09/10/1997 | EP0794175A2 Process for producing vitamin D3 derivatives |
| 09/10/1997 | EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 09/10/1997 | EP0794171A2 Orthosubstituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic material and medicaments containing them |
| 09/10/1997 | EP0793963A1 Percutaneously administrable preparation |
| 09/10/1997 | EP0793962A1 Medicament containing a carnitine derivative for treating arteriosclerosis obliterans |
| 09/10/1997 | EP0793961A1 Use of droloxifene for the manufacture of a medicament for increasing serum levels of testosterone |
| 09/10/1997 | EP0793960A1 Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia |
| 09/10/1997 | EP0793959A1 Controlled-release composition |